Yangyi Bao

Hefei, 230001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

miR-181b-5p promotes cell proliferation and induces apoptosis in human acute myeloid leukemia by targeting PAX9

miR-181b-5p promotes cell proliferation and induces apoptosis in human acute myeloid leukemia by targeting PAX9

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: December 23, 2023

Clinical Significance of EZH2 in Acute Myeloid Leukemia.

Clinical Significance of EZH2 in Acute Myeloid Leukemia.

Journal: Computational intelligence and neuroscience

Published: June 23, 2022

Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind study.

Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind study.

Journal: EClinicalMedicine

Published: June 21, 2021

HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells.

HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells.

Journal: Cell chemical biology

Published: June 05, 2019

The clinical study on treatment of CD19-directed chimeric antigen receptor-modified T cells in a case of refractory Richter syndrome.

The clinical study on treatment of CD19-directed chimeric antigen receptor-modified T cells in a case of refractory Richter syndrome.

Journal: Cancer medicine

Published: September 28, 2018

Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling.

Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: May 16, 2018

Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential.

Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential.

Journal: International journal of nanomedicine

Published: March 24, 2017

Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5

Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: February 24, 2017

Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.

Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.

Journal: Oncotarget

Published: October 07, 2016

Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo.

Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: July 26, 2016

Mechanism of Killing Effect of Thioridazine on Human Lung Cancer PC9 Cells

Mechanism of Killing Effect of Thioridazine on Human Lung Cancer PC9 Cells

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: December 29, 2015

IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways.

IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways.

Journal: Oncotarget

Published: December 06, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026